Michael Oeverhaus
Overview
Explore the profile of Michael Oeverhaus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Ghazzawi K, Neumann I, Knetsch M, Chen Y, Wilde B, Bechrakis N, et al.
J Clin Med
. 2024 Jul;
13(14).
PMID: 39064038
: To clarify the therapy response in orbital inflammatory diseases (OID), we analyzed the treatment effects of steroid therapy, the use of disease-modifying antirheumatic drugs (DMARDS), and biologicals in our...
2.
Oeverhaus M, Neumann I, Chen Y, Eckstein A
Ophthalmologie
. 2024 Jun;
121(7):548-553.
PMID: 38922402
Background: Endocrine orbitopathy (EO) is an autoimmune disease mostly associated with a disease of the thyroid gland, which leads to inflammation, adipogenesis and fibrosis. The severity of EO can vary...
3.
Oeverhaus M, Sander J, Smetana N, Bechrakis N, Inga N, Al-Ghazzawi K, et al.
J Clin Med
. 2024 Jan;
13(1).
PMID: 38202297
Purpose: Graves' orbitopathy (GO) is an autoimmune disorder leading to inflammation, adipogenesis, and fibrosis. The severity of GO can vary widely among individuals, making it challenging to predict the natural...
4.
Stohr M, Dekowski D, Bechrakis N, Oeverhaus M, Eckstein A
Ophthalmology
. 2023 Nov;
131(5):545-556.
PMID: 38000547
Purpose: Patients with incurable corneal diseases experience visual impairment (VI) despite having a healthy retina and optic pathway. Low-vision aids (LVAs) can optimize the use of remaining vision through magnification...
5.
Eckstein A, Stohr M, Gortz G, Gulbins A, Moller L, Fuehrer-Sakel D, et al.
Klin Monbl Augenheilkd
. 2023 Oct;
241(1):48-68.
PMID: 37799096
Graves' orbitopathy is an autoimmune disease of the orbit that most frequently occurs with Graves' hyperthyroidism. The occurrence of autoantibodies directed against the TSH receptor (TRAb) is of central importance...
6.
Gulbins A, Horstmann M, Daser A, Flogel U, Oeverhaus M, Bechrakis N, et al.
Front Endocrinol (Lausanne)
. 2023 Jul;
14:1211473.
PMID: 37435490
Introduction: Graves' disease (GD) is an autoimmune disorder caused by autoantibodies against the thyroid stimulating hormone receptor (TSHR) leading to overstimulation of the thyroid gland. Thyroid eye disease (TED) is...
7.
Oeverhaus M, Winkler L, Stahr K, Daser A, Bechrakis N, Stohr M, et al.
Front Endocrinol (Lausanne)
. 2023 Apr;
14:1160172.
PMID: 37082130
Purpose: Severity of Graves' orbitopathy (GO) shows wide individual differences. For optimal treatment, it is important to be able to predict the natural course of the disease as accurate as...
8.
Oeverhaus M, Stohr M, Moller L, Fuhrer D, Eckstein A
Laryngorhinootologie
. 2023 Mar;
102(3):177-185.
PMID: 36858060
Background: The therapy of severe manifestations of Graves' orbitopathy (GO) is still a challenge and requires good interdisciplinary cooperation. It is especially important to use stage-adapted anti-inflammatory therapy to avoid...
9.
Gortz G, Philipp S, Bruderek K, Jesenek C, Horstmann M, Henning Y, et al.
Endocrinology
. 2022 Dec;
164(2).
PMID: 36477465
The inflammatory eye disease Graves' orbitopathy (GO) is the main complication of autoimmune Graves' disease. In previous studies we have shown that hypoxia plays an important role for progression of...
10.
Oeverhaus M, Koenen J, Bechrakis N, Stohr M, Herrmann K, Fendler W, et al.
J Nucl Med
. 2022 Nov;
64(4):561-566.
PMID: 36418167
Our purpose was to assess response after ablation of thyroid remnants (ATR) with radioactive iodine therapy in patients with unstable Graves' orbitopathy (GO) after subtotal thyroidectomy. Thirty patients with mild...